CML is characterized by the essentially uniform finding of a chromosomal translocation between chromosomes 9 and 22 yielding a fusion kinase BCR/ABL [6, 7]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.